The recombinant variants of SARS-CoV-2: Concerns continues amid COVID-19 pandemic

J Med Virol. 2022 Aug;94(8):3506-3508. doi: 10.1002/jmv.27780. Epub 2022 Apr 27.

Authors

Ranjan K Mohapatra¹, Venkataramana Kandi², Hardeep S Tuli³, Chiranjib Chakraborty⁴, Kuldeep Dhama⁵

Affiliations

¹ Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India.
² Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India.
³ Department of Biotechnology, Maharishi Markandeshwar University, Mullana, Haryana, India.
⁴ Department of Biotechnology, Adamas University, Kolkata, West Bengal, India.
⁵ Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Viral
COVID-19* / epidemiology
Humans
Pandemics
SARS-CoV-2* / genetics
Spike Glycoprotein, Coronavirus / genetics

Substances

Antibodies, Viral
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2